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Background
It was recently hypothesized that the lentiviral reservoir
in central memory (TCM) and transitional memory
(TTM) CD4+ cells could be restricted by new therapies
targeting pathways downstream of homeostatic prolif-
eration or pathways associated with “stem cell–ness”,
such as those developed for the treatment of leukemias.
Gar1041 is one such epigenetic drug adopted in the
experimental treatment of certain types of leukemia.
Methods
SIVmac251-infected primates with viral loads stably sup-
pressed by ART (tenofovir/emtricitabine/raltegravir)
were administered for two months: Gar1041 twice daily
(a starting dose of 1.5g in the first week followed by 2g
in the remaining period). ART was continued during
Gar1041 treatment. Proviral DNA was quantitated using
a Taqman real-time PCR.
Results
The proviral DNA content of PBMCs, which had shown
no significant changes during 54 days of treatment with
ART alone (p >0.05), fell below the level of detection (2
copies/10
6 cells) in all study subjects within one month
of Gar1041 treatment (p <0.05; Bonferroni’s test following
significant [p=0.0003] repeated measures ANOVA). No
significant changes were noticed in a control group trea-
ted with ART alone (p=0.49). The decrease in proviral
DNA was associated with a significant (p=0.0156)
decrease in the proportions of the TCM CD4+ cell subpo-
pulation in peripheral blood. However, both proviral
DNA and the proportions of TCM CD4+ rebound after
two months of therapy.
Conclusions
The present study furnishes proof of concept that phar-
macological strategies may impact on the proviral DNA
reservoir. However, the renewal of the phenotype TCM
compartment, associated with the reconstitution of pro-
viral DNA in peripheral blood from an as yet unidenti-
fied reservoir, will require integration with other
experimental approaches.
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